Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci
about
Newer antibacterial drugs for a new century.Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data.Ketolide resistance in Streptococcus pyogenes correlates with the degree of rRNA dimethylation by Erm.In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United StatesKetolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae.Novel antibacterial agents for the treatment of serious Gram-positive infections.Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniaeCethromycin versus clarithromycin for community-acquired pneumonia: comparative efficacy and safety outcomes from two double-blinded, randomized, parallel-group, multicenter, multinational noninferiority studies.Efflux-mediated antimicrobial resistance.High prevalence of the ermB gene among erythromycin-resistant streptococcus pneumoniae isolates in Germany during the winter of 2000-2001 and in vitro activity of telithromycin.Interaction of the new ketolide ABT-773 (cethromycin) with human polymorphonuclear neutrophils and the phagocytic cell line PLB-985 in vitroCethromycin: a promising new ketolide antibiotic for respiratory infections.Cethromycin: a new ketolide antibiotic.Speculative strategies for new antibacterials: all roads should not lead to Rome.The macrolide antibiotic renaissance.Resistance to macrolides and related antibiotics in Streptococcus pneumoniaeActivities of ABT-773 against Listeria monocytogenes and coryneform bacteria of clinical interest.Comparison of emm typing and ribotyping with three restriction enzymes to characterize clinical isolates of Streptococcus pyogenes.New acylides: synthesis of 3-O-[gamma-(4-oxo-2-aryl-thiazolidin-3-yl)butyryl]erythromycin A derivatives.Distinct mode of interaction of a novel ketolide antibiotic that displays enhanced antimicrobial activity.Differences in the DNA sequences in the upstream attenuator region of erm(A) in clinical isolates of Streptococcus pyogenes and their correlation with macrolide/lincosamide resistance.A Novel indole compound that inhibits Pseudomonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprMEfficacy of cethromycin, a new ketolide, against Streptococcus pneumoniae susceptible or resistant to erythromycin in a murine pneumonia model.Mobile elements and chromosomal changes associated with MLS resistance phenotypes of invasive pneumococci recovered in the United States.In vitro activity of telithromycin against mefA and ermB erythromycin-resistant viridans streptococci isolated from bacteremia of oral origin in Spain.
P2860
Q30433333-8E00AE65-D671-4B07-A8D7-164AA7E8AD75Q30806051-3F3A9950-5A28-447C-9BB3-B5076D273763Q33224241-119031F8-657D-4357-8CF4-E075B3A7B83DQ33836624-4CA8BDC0-4B38-4D67-8366-3A93BE6199B7Q34281970-E6E3F24F-74D3-4AD8-8ADC-A4C4E687A6B2Q35073345-B3A0F6B1-21B4-40FA-99D7-4EF9A031F285Q35547345-558A29FF-D976-486D-BF82-63ED9434C9EAQ35867451-9EFCAD07-23EE-44E0-A434-50044A4D2D3AQ36138147-EF62976E-3E25-4276-A692-0EA094825F9DQ36670675-EC16F713-B708-413B-B3C9-FF8563227373Q37119314-AF665BBC-B141-4969-9AF8-FFB93657D6DAQ37697782-033BDB08-3EA3-44CB-8898-BAE0D6667BAEQ38086821-DF51FC7D-272D-4711-8E20-17C358413126Q38101243-E9A0F91E-BCBC-435F-8FA8-7391211E2DB2Q39406507-64C864B7-F96F-455A-8967-D9878E65D193Q39652725-CCB08310-BF3A-47FD-900C-321C926002C2Q39743406-DEDF9286-174B-40EA-90CA-2C349A28F8BDQ40771253-970E88DF-984E-42CF-BFF5-E7FD8E398B12Q40989374-99264368-A617-45C1-81C0-CAB5C634C0A5Q41900813-E27C332C-17E2-4E59-BC19-223F422FF026Q41922346-2B3A796B-E53D-48F0-844E-89715DBF376FQ42637266-309EAAA8-8F04-40E7-90F1-7BD651EF135BQ43151670-E2B4DDA3-BAD2-4C14-BFEE-CD10833CC304Q43830993-F4CEFF05-76BA-4B2E-A01A-71DC6C06F9FDQ45197075-A7CB51A0-278C-47DC-810B-EA48E42FFBF9
P2860
Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Comparison of in vitro activit ...... streptococci and staphylococci
@en
Comparison of in vitro activit ...... treptococci and staphylococci.
@nl
type
label
Comparison of in vitro activit ...... streptococci and staphylococci
@en
Comparison of in vitro activit ...... treptococci and staphylococci.
@nl
prefLabel
Comparison of in vitro activit ...... streptococci and staphylococci
@en
Comparison of in vitro activit ...... treptococci and staphylococci.
@nl
P2093
P2860
P1476
Comparison of in vitro activit ...... streptococci and staphylococci
@en
P2093
Jill M Beyer
Laurel S Almer
Nancy C Ramer
Ping Zhong
Stella Z Doktor
Virginia D Shortridge
Zhensheng Cao
P2860
P304
P356
10.1128/AAC.46.3.783-786.2002
P407
P577
2002-03-01T00:00:00Z